Your browser doesn't support javascript.
loading
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1).
Mi, Jian-Qing; Zhao, Wanhong; Jing, Hongmei; Fu, Weijun; Hu, Jianda; Chen, Lijuan; Zhang, Yiwen; Yao, Dan; Chen, Diana; Schecter, Jordan M; Yang, Fan; Tian, Xiaochen; Sun, Huabin; Zhuang, Sen Hong; Ren, Jimmy; Fan, Xiaohu; Jin, Jie; Niu, Ting; Chen, Sai-Juan.
Afiliación
  • Mi JQ; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhao W; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, China.
  • Jing H; Peking University Third Hospital, Beijing, China.
  • Fu W; Shanghai Changzheng Hospital and Department of Hematology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Hu J; Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Chen L; Jiangsu Province Hospital, Nanjing, Jiangsu, China.
  • Zhang Y; Legend Biotech China, Nanjing, Jiangsu, China.
  • Yao D; Janssen China Research & Development, Shanghai, China.
  • Chen D; Janssen China Research & Development, Shanghai, China.
  • Schecter JM; Janssen Research & Development, Raritan, NJ.
  • Yang F; Janssen China Research & Development, Shanghai, China.
  • Tian X; Janssen China Research & Development, Shanghai, China.
  • Sun H; Janssen Research & Development, Raritan, NJ.
  • Zhuang SH; Janssen China Research & Development, Shanghai, China.
  • Ren J; Janssen China Research & Development, Shanghai, China.
  • Fan X; Legend Biotech China, Nanjing, Jiangsu, China.
  • Jin J; First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China.
  • Niu T; West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Chen SJ; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Clin Oncol ; 41(6): 1275-1284, 2023 02 20.
Article en En | MEDLINE | ID: mdl-36269898
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Anemia / Mieloma Múltiple Límite: Adult / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Anemia / Mieloma Múltiple Límite: Adult / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: China